0001209191-20-054996.txt : 20201015
0001209191-20-054996.hdr.sgml : 20201015
20201015202630
ACCESSION NUMBER: 0001209191-20-054996
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201015
FILED AS OF DATE: 20201015
DATE AS OF CHANGE: 20201015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horowitz Limited Partnership VIII
CENTRAL INDEX KEY: 0001827839
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 201242555
BUSINESS ADDRESS:
STREET 1: 5030 CAMPUS DRIVE, SUITE A
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
BUSINESS PHONE: (949) 831-5158
MAIL ADDRESS:
STREET 1: 5030 CAMPUS DRIVE, SUITE A
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001819790
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 814717861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 409-9820
MAIL ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-10-15
0
0001819790
Tarsus Pharmaceuticals, Inc.
TARS
0001827839
Horowitz Limited Partnership VIII
5030 CAMPUS DRIVE, SUITE A
NEWPORT BEACH
CA
92660
0
0
1
0
Series A Preferred Stock
Common Stock
1434790
D
Series B Preferred Stock
Common Stock
245966
D
Series C Preferred Stock
Common Stock
71427
D
Series A Preferred Stock
Common Stock
43151
I
By the Adam S. Horowitz Revocable Trust
Series B Preferred Stock
Common Stock
7396
I
By the Adam S. Horowitz Revocable Trust
The Series A Preferred Stock shall automatically convert into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"), on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock has no expiration date.
The Series B Preferred Stock shall automatically convert into shares of Common Stock, on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock has no expiration date.
The Series C Preferred Stock shall automatically convert into shares of Common Stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series C Preferred Stock has no expiration date.
The shares are held by the Adam S. Horowitz Revocable Trust, of which Adam S. Horowitz is Trustee. Adam S. Horowitz is affiliated with Horowitz Limited Partnership VIII.
/s/ Jason Tester, as Chief Financial Officer of Horowitz Management, Inc., the managing partner of Horowitz Limited Partnership VIII
2020-10-15